134 related articles for article (PubMed ID: 18239285)
1. Formulations for protecting the probiotic Saccharomyces boulardii from degradation in acidic condition.
Graff S; Chaumeil JC; Boy P; Lai-Kuen R; Charrueau C
Biol Pharm Bull; 2008 Feb; 31(2):266-72. PubMed ID: 18239285
[TBL] [Abstract][Full Text] [Related]
2. Influence of pH conditions on the viability of Saccharomyces boulardii yeast.
Graff S; Chaumeil JC; Boy P; Lai-Kuen R; Charrueau C
J Gen Appl Microbiol; 2008 Aug; 54(4):221-7. PubMed ID: 18802321
[TBL] [Abstract][Full Text] [Related]
3. Increased intestinal delivery of viable Saccharomyces boulardii by encapsulation in microspheres.
Graff S; Hussain S; Chaumeil JC; Charrueau C
Pharm Res; 2008 Jun; 25(6):1290-6. PubMed ID: 18188682
[TBL] [Abstract][Full Text] [Related]
4. Effect of whey protein agglomeration on spray dried microcapsules containing Saccharomyces boulardii.
Duongthingoc D; George P; Katopo L; Gorczyca E; Kasapis S
Food Chem; 2013 Dec; 141(3):1782-8. PubMed ID: 23870891
[TBL] [Abstract][Full Text] [Related]
5. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
Kasliwal N; Negi JS; Jugran V; Jain R
Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
[TBL] [Abstract][Full Text] [Related]
6. Properties and stability of Lactiplantibacillus plantarum AB6-25 and Saccharomyces boulardii T8-3C single and double-layered microcapsules containing Na-alginate and/or demineralized whey powder with lactobionic acid.
Gedik O; Karahan AG
Int J Biol Macromol; 2024 Jun; 271(Pt 1):132406. PubMed ID: 38754658
[TBL] [Abstract][Full Text] [Related]
7. Towards effective and stable probiotics.
Yarullina DR; Damshkaln LG; Bruslik NL; Konovalova OA; Ilinskaya ON; Lozinsky VI
Int J Risk Saf Med; 2015; 27 Suppl 1():S65-6. PubMed ID: 26639716
[TBL] [Abstract][Full Text] [Related]
8. Oral Delivery of Probiotics in Poultry Using pH-Sensitive Tablets.
Jiang T; Li HS; Han GG; Singh B; Kang SK; Bok JD; Kim DD; Hong ZS; Choi YJ; Cho CS
J Microbiol Biotechnol; 2017 Apr; 27(4):739-746. PubMed ID: 28081355
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive optimization of composite cryoprotectant for
Guowei S; Yang X; Li C; Huang D; Lei Z; He C
Prep Biochem Biotechnol; 2019; 49(9):846-857. PubMed ID: 31244369
[No Abstract] [Full Text] [Related]
10. Quality control of fifteen probiotic products containing Saccharomyces boulardii.
Vanhee LM; Goemé F; Nelis HJ; Coenye T
J Appl Microbiol; 2010 Nov; 109(5):1745-52. PubMed ID: 20636342
[TBL] [Abstract][Full Text] [Related]
11. Oral Delivery of Probiotics Using pH-Sensitive Phthalyl Inulin Tablets.
Kim WS; Cho CS; Hong L; Han GG; Kil BJ; Kang SK; Kim DD; Choi YJ; Huh CS
J Microbiol Biotechnol; 2019 Feb; 29(2):200-208. PubMed ID: 30691251
[TBL] [Abstract][Full Text] [Related]
12. Coated whey protein/alginate microparticles as oral controlled delivery systems for probiotic yeast.
Hébrard G; Hoffart V; Beyssac E; Cardot JM; Alric M; Subirade M
J Microencapsul; 2010; 27(4):292-302. PubMed ID: 20163284
[TBL] [Abstract][Full Text] [Related]
13. Spray-dried microspheres containing ketoprofen formulated into capsules and tablets.
Moretti MD; Gavini E; Juliano C; Pirisino G; Giunchedi P
J Microencapsul; 2001; 18(1):111-21. PubMed ID: 11201334
[TBL] [Abstract][Full Text] [Related]
14. Development of microparticulate systems for intestinal delivery of Lactobacillus acidophilus and Bifidobacterium lactis.
Albertini B; Vitali B; Passerini N; Cruciani F; Di Sabatino M; Rodriguez L; Brigidi P
Eur J Pharm Sci; 2010 Jul; 40(4):359-66. PubMed ID: 20420903
[TBL] [Abstract][Full Text] [Related]
15. Microencapsulation of Probiotic
Lee Y; Ji YR; Lee S; Choi MJ; Cho Y
J Microbiol Biotechnol; 2019 May; 29(5):721-730. PubMed ID: 31030452
[TBL] [Abstract][Full Text] [Related]
16. Survival of freeze-dried microcapsules of α-galactosidase producing probiotics in a soy bar matrix.
Chen M; Mustapha A
Food Microbiol; 2012 May; 30(1):68-73. PubMed ID: 22265285
[TBL] [Abstract][Full Text] [Related]
17. Optimized tableting for extremely oxygen-sensitive probiotics using direct compression.
Allouche R; Dupont S; Charriau A; Gervais P; Beney L; Chambin O
Int J Pharm; 2018 Mar; 538(1-2):14-20. PubMed ID: 29307771
[TBL] [Abstract][Full Text] [Related]
18. Effect of freeze-drying on viability and in vitro probiotic properties of a mixture of lactic acid bacteria and yeasts isolated from kefir.
Bolla PA; Serradell Mde L; de Urraza PJ; De Antoni GL
J Dairy Res; 2011 Feb; 78(1):15-22. PubMed ID: 20822567
[TBL] [Abstract][Full Text] [Related]
19. Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.
Hudson LE; Fasken MB; McDermott CD; McBride SM; Kuiper EG; Guiliano DB; Corbett AH; Lamb TJ
PLoS One; 2014; 9(11):e112660. PubMed ID: 25391025
[TBL] [Abstract][Full Text] [Related]
20. Review article: yeast as probiotics -- Saccharomyces boulardii.
Czerucka D; Piche T; Rampal P
Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
